CELC
Price
$10.24
Change
+$0.25 (+2.50%)
Updated
Apr 17 closing price
Capitalization
378.02M
31 days until earnings call
COGT
Price
$4.37
Change
+$0.10 (+2.34%)
Updated
Apr 17 closing price
Capitalization
497.52M
25 days until earnings call
Ad is loading...

CELC vs COGT

Header iconCELC vs COGT Comparison
Open Charts CELC vs COGTBanner chart's image
Celcuity
Price$10.24
Change+$0.25 (+2.50%)
Volume$165.33K
Capitalization378.02M
Cogent Biosciences
Price$4.37
Change+$0.10 (+2.34%)
Volume$1.16M
Capitalization497.52M
CELC vs COGT Comparison Chart
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELC vs. COGT commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Hold and COGT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (CELC: $10.24 vs. COGT: $4.37)
Brand notoriety: CELC and COGT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 57% vs. COGT: 84%
Market capitalization -- CELC: $378.02M vs. COGT: $497.52M
CELC [@Biotechnology] is valued at $378.02M. COGT’s [@Biotechnology] market capitalization is $497.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whileCOGT’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • COGT’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 5 TA indicator(s) are bullish while COGT’s TA Score has 4 bullish TA indicator(s).

  • CELC’s TA Score: 5 bullish, 2 bearish.
  • COGT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CELC is a better buy in the short-term than COGT.

Price Growth

CELC (@Biotechnology) experienced а +18.38% price change this week, while COGT (@Biotechnology) price change was +8.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

CELC is expected to report earnings on Aug 07, 2025.

COGT is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($498M) has a higher market cap than CELC($378M). CELC YTD gains are higher at: -21.772 vs. COGT (-43.974). CELC has higher annual earnings (EBITDA): -85.45M vs. COGT (-271.59M). COGT has more cash in the bank: 287M vs. CELC (264M). COGT has less debt than CELC: COGT (17.5M) vs CELC (97.2M). CELC (0) and COGT (0) have equivalent revenues.
CELCCOGTCELC / COGT
Capitalization378M498M76%
EBITDA-85.45M-271.59M31%
Gain YTD-21.772-43.97450%
P/E RatioN/AN/A-
Revenue00-
Total Cash264M287M92%
Total Debt97.2M17.5M555%
FUNDAMENTALS RATINGS
CELC vs COGT: Fundamental Ratings
CELC
COGT
OUTLOOK RATING
1..100
1452
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
81
Overvalued
PROFIT vs RISK RATING
1..100
8378
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
7895
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CELC's Valuation (46) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for COGT (81) in the Miscellaneous industry. This means that CELC’s stock grew somewhat faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (78) in the Miscellaneous industry is in the same range as CELC (83) in the Miscellaneous Commercial Services industry. This means that COGT’s stock grew similarly to CELC’s over the last 12 months.

CELC's SMR Rating (95) in the Miscellaneous Commercial Services industry is in the same range as COGT (96) in the Miscellaneous industry. This means that CELC’s stock grew similarly to COGT’s over the last 12 months.

CELC's Price Growth Rating (78) in the Miscellaneous Commercial Services industry is in the same range as COGT (95) in the Miscellaneous industry. This means that CELC’s stock grew similarly to COGT’s over the last 12 months.

CELC's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as COGT (100) in the Miscellaneous industry. This means that CELC’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELCCOGT
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 11 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GACIX39.94N/A
N/A
Gabelli Small Cap Growth I
CHUSX24.71N/A
N/A
Alger Global Equity A
FZAJX19.76N/A
N/A
Fidelity Advisor International Growth Z
IHSIX19.18N/A
N/A
Hartford Small Company I
BMIYX6.48N/A
N/A
BNY Mellon Income Stock Y

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with ABOS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+2.50%
ABOS - CELC
46%
Loosely correlated
-8.08%
PRME - CELC
45%
Loosely correlated
N/A
CLDX - CELC
44%
Loosely correlated
+2.81%
ELVN - CELC
42%
Loosely correlated
+2.86%
NUVB - CELC
42%
Loosely correlated
+4.79%
More

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+2.34%
SPHDF - COGT
63%
Loosely correlated
N/A
ETNB - COGT
50%
Loosely correlated
+2.89%
ARWR - COGT
50%
Loosely correlated
-0.97%
XNCR - COGT
48%
Loosely correlated
+1.89%
CRNX - COGT
47%
Loosely correlated
+2.84%
More